CLOV
Clover Health Investments Co
NASDAQ · Health Care
$2.13
+0.09 (+4.41%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.45B | 1.48B | 257.72M | 264.97M | 231.04M |
| Net Income | -45,364,495 | -41,806,313 | 37.27M | 45.14M | 34.96M |
| EPS | — | — | — | — | — |
| Profit Margin | -3.1% | -3.0% | 14.5% | 17.0% | 15.1% |
| Rev Growth | -2.3% | -2.3% | +23.9% | -4.7% | +0.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 269.55M | 233.18M | 276.16M |
| Total Equity | — | — | 629.60M | 675.38M | 742.87M |
| D/E Ratio | — | — | 0.43 | 0.35 | 0.37 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -46,862,867 | -45,586,446 | 71.88M | 76.57M | 66.07M |
| Free Cash Flow | — | — | 30.93M | 32.12M | 25.98M |